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Internal carotid artery (ACI) stenosis is a common cause of ischemic stroke. Stenoses above 70% are 
considered as clinically significant. Treatment of a high-grade carotid stenosis is either surgical or 
endovascular and carotid stenting (CAS) is used as the method of choice in indicated patients.  
Case presentation: 
We report a 57-year-old female patient who was admitted to the hospital due to recurrent transient 
ischemic attacks (TIA) with clinical presentation of dysarthria and leftsided faciobrachiparesis with 
sensory loss. The patient suffered from hypertension and had a record of cerebrovascular occurrences 
in family history. MRI showed acute hypoperfusion lesions, and CT angiography confirmed 
symptomatic high-grade stenosis of right ACI. The left ACI was occluded. The patient underwent a 
successful right-sided CAS. Immediate carotid ultrasound finding was accordingly and the patient was 
discharged on dual therapy with Aspirin and clopidogrel. Three months after the procedure, the patient 
was re-admitted due to reoccurrence of TIA with motor, sensory and visual impairment in the left half 
of the body. Control angiography indicated the presence of “in-stent” stenosis. Ultrasound revealed a 
thrombus in the proximal part of the stent, and aggregometric treatment showed complete non-
reactivity to both antithrombotic drugs. The patient underwent balloon dilatation of the stenosis, after 
which only insignificant (<30%) stenosis remained. Alternative antithrombotic therapy with ticagrelor 
was introduced. With neurological status improved, the patient was discharged. Follow-ups after one 
and two years showed normal flow through the stent.  
Conclusion: 
Dual antiagregation is a common therapy after carotid stenting, during first three months followed by 
acetylsalicylic acid long-term. We present a patient with an extremely rare combination of resistance to 
both drugs and a clinically relevant in-stent thrombosis. This case illustrates the importance of regular 
follow-ups after CAS as well as the choice of the appropriate antithrombotic therapy in secondary 
prevention of stroke.  
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